Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Beasley

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 4, 1999
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trialD A Revicki, L A Genduso, S H Hamilton, et al.
Psychiatric Services (Washington, D.C.)|December 24, 1997
Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophreniaM A Dellva, P Tran, G D Tollefson, et al.
The Journal of Clinical Psychiatry|August 1, 1993
Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reductionD J Goldstein, A H Rampey, J H Potvin, et al.
The Journal of Clinical Psychiatry|July 1, 1991
Fluoxetine versus trazodone: efficacy and activating-sedating effectsC M Beasley, B E Dornseif, J A Pultz, et al.
Journal of Affective Disorders|November 1, 1990
Fluoxetine in tricyclic refractory major depressive disorderC M Beasley, M E Sayler, G E Cunningham, et al.
Journal of Clinical Psychopharmacology|June 1, 1994
Absence of a relationship between adverse events and suicidality during pharmacotherapy for depressionG D Tollefson, A H Rampey, C M Beasley, et al.
Journal of Clinical Psychopharmacology|October 1, 1993
Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findingsC M Beasley, D N Masica, J H Heiligenstein, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 26, 1998
Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychosesP V Tran, M A Dellva, G D Tollefson, et al.
The American Journal of Psychiatry|September 1, 1997
Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidolG D Tollefson, C M Beasley, R N Tamura, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 22, 1999
Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapyP V Tran, G D Tollefson, T M Sanger, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 4, 1999
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trialD A Revicki, L A Genduso, S H Hamilton, et al.
Psychiatric Services (Washington, D.C.)|December 24, 1997
Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophreniaM A Dellva, P Tran, G D Tollefson, et al.
The Journal of Clinical Psychiatry|August 1, 1993
Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reductionD J Goldstein, A H Rampey, J H Potvin, et al.
The Journal of Clinical Psychiatry|July 1, 1991
Fluoxetine versus trazodone: efficacy and activating-sedating effectsC M Beasley, B E Dornseif, J A Pultz, et al.
Journal of Affective Disorders|November 1, 1990
Fluoxetine in tricyclic refractory major depressive disorderC M Beasley, M E Sayler, G E Cunningham, et al.
Journal of Clinical Psychopharmacology|June 1, 1994
Absence of a relationship between adverse events and suicidality during pharmacotherapy for depressionG D Tollefson, A H Rampey, C M Beasley, et al.
Journal of Clinical Psychopharmacology|October 1, 1993
Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findingsC M Beasley, D N Masica, J H Heiligenstein, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 26, 1998
Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychosesP V Tran, M A Dellva, G D Tollefson, et al.
The American Journal of Psychiatry|September 1, 1997
Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidolG D Tollefson, C M Beasley, R N Tamura, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 22, 1999
Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapyP V Tran, G D Tollefson, T M Sanger, et al.
Pageof 6